Last Posted: Aug 14, 2020
- Role of POLE and POLD1 in familial cancer
P Mur et al, Genetics in Medicine, August 14, 2020 - Exon splicing analysis of intronic variants in multi-gene cancer panel testing for hereditary breast/ovarian cancer.
Ryu Jin-Sun et al. Cancer science 2020 Aug - Stakeholder perspectives on overcoming barriers to cascade testing in Lynch syndrome: A qualitative study.
Srinivasan Swetha et al. Cancer prevention research (Philadelphia, Pa.) 2020 Jul - Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example.
Hemminki Kari et al. Hereditary cancer in clinical practice 2020 1815 - A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen).
Ritter Deborah I et al. Cold Spring Harbor molecular case studies 2019 5(5) - Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.
Brandão Andreia et al. International journal of molecular sciences 2020 Jul 21(14) - Whether, when, and how to communicate genetic risk to minors: 'I wanted more information but I think they were scared I couldn't handle it'.
Stuttgen Kelsey et al. Journal of genetic counseling 2020 Jul - Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
Horiuchi Yasue et al. Human genetics 2020 Jul - The Community Oncology and Academic Medical Center Alliance in the Age of Precision Medicine: Cancer Genetics and Genomics Considerations.
Melas Marilena et al. Journal of clinical medicine 2020 Jul 9(7) - A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromes.
Peacock Oliver et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2019 Dec 45(12) 2241-2250
.png)
No hay comentarios:
Publicar un comentario